Average Co-Inventor Count = 5.30
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (43 from 2,079 patents)
2. Respivert Limited (8 from 63 patents)
3. Topivert Pharma Limited (2 from 26 patents)
51 patents:
1. 12215111 - Imidazopyridazine IL-17 inhibitor compounds
2. 12065446 - Inhibitors of Bruton's tyrosine kinase and method of their use
3. 11897900 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
4. 11827638 - Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
5. 11634406 - Inhibitor of p38 MAP kinase
6. 11427601 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
7. 11319329 - Inhibitors of Bruton's tyrosine kinase and methods of their use
8. 11142515 - Pyrazolyl-ureas as kinase inhibitors
9. 10981911 - Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
10. 10947252 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
11. 10934310 - Inhibitors of Bruton's tyrosine kinase and method of their use
12. 10822348 - Inhibitors of Bruton's tyrosine kinase and methods of their use
13. 10815217 - Inhibitor of p38 MAP kinase
14. 10800792 - Inhibitors of Bruton's tyrosine kinase and method of their use
15. 10717745 - Inhibitors of Bruton's tyrosine kinase and method of their use